New heart valve device tested in High-Risk chinese patients
NCT ID NCT04982588
First seen Dec 08, 2025 · Last updated Apr 29, 2026 · Updated 19 times
Summary
This study is testing a new heart valve device (Medtronic CoreValve Evolut PRO) in 52 Chinese patients with severe aortic stenosis who are too high-risk for open-heart surgery. The device is placed through a tube in an artery to replace the diseased valve without major surgery. Researchers are checking how many patients survive and if the new valve leaks at 30 days after the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE, SYMPTOMATIC AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, 100000, China
-
Chinese PLA General Hospital, Chinese PLA Medical School
Beijing, Beijing Municipality, 100000, China
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610000, China
Conditions
Explore the condition pages connected to this study.